 |
| Top Story | |
 |
TPF Survival Benefit Sustained in TAX 324 Trial
Elsevier Global Medical News, 2009 Oct 15, P Wendling
Induction with docetaxel, cisplatin, and 5-fluorouracil offers a sustained survival advantage in head and neck squamous cell carcinoma.
|
| Weekly News | More » |
|
Higher Recurrence Rate Seen in Triple-Negative, Locally Advanced Breast Cancer
Elsevier Global Medical News, 2009 Oct 15, S Boschert
Patients who were treated with neoadjuvant therapy were more likely to develop clinical recurrence if they had a triple-negative tumor subtype.
|
Paclitaxel Does Not Help Women With Luminal A Breast Cancer
Elsevier Global Medical News, 2009 Oct 15, S Boschert
EXPERT COMMENTARY
Women with the most common, least aggressive subtype of breast cancer do not benefit from the addition of paclitaxel to adjuvant chemotherapy.
|
Most Breast Cancer Deaths Occur in Women Who Don't Get Routine Mammograms
Elsevier Global Medical News, 2009 Oct 15, S Boschert
Unscreened women over age 40 accounted for 75% of deaths in an analysis of data on 6997 invasive breast cancers diagnosed from 1990 to 1999 and followed through 2007.
|
Neoadjuvant Erlotinib May Prolong Survival in Advanced Bladder Cancer
Elsevier Global Medical News, 2009 Oct 14, D McNamara
Neoadjuvant treatment with the kinase inhibitor erlotinib might increase survival, compared with traditional radical cystectomy alone.
|
HER2/neu Vaccine Tested in Metastatic Breast Cancer
Elsevier Global Medical News, 2009 Oct 14, HP Chee
A virosome-based multipeptide vaccine targeting HER2/neu was found to be safe and well tolerated in a phase I breast cancer study.
|
No Evidence of Mastectomy Overuse in Large Survey
Elsevier Global Medical News, 2009 Oct 13, R Finn
More than three-quarters of women newly diagnosed with intraductal or stage I or II breast cancer elected breast-conserving surgery.
|
Minimally Invasive Prostatectomy Better on Some Measures Than Retropubic Prostatectomy, Worse on Others
Elsevier Global Medical News, 2009 Oct 13, R Finn
Men who underwent minimally invasive vs retropubic radical prostatectomy had shorter hospital stays and lost less blood during surgery.
|
Senate Finance Committee Passes Health Reform Bill
Elsevier Global Medical News, 2009 Oct 13, J Frieden
After months of debate, the Finance Committee voted 14-9 to pass a bill aimed at expanding health coverage and making health insurance more affordable.
|
GSK's RCC Agent Votrient Clears ODAC Despite Outdated Trial, FDA Safety Concerns
The Pink Sheet Daily, 2009 Oct 12, J Hammon
Comparison of a new oncologic agent with the current standard of care may not be required if the trial predated establishment of that standard.
|
|
| | |
| BREAST CANCER SYMPOSIUM
Read conference news from this year's multidisciplinary event.
VISIT SITE
| |
|
|
| | |
| COMMENTARY
Dr. David Henry focuses on some of the studies presented at ECCO/ESMO that may change or influence practice.
VISIT SITE
| |
|
|
|
Week in Review
